玻尿酸填充物市场:开发平台报告(开发阶段，市场区隔，地区·国家，法规途径，主要企业)，2024年最新版

玻尿酸 (HA) 是一种体内天然存在的醣胺聚醣二糖。大约 50% 的 HA 存在于皮肤中，由真皮纤维母细胞、内皮细胞、滑膜细胞、外膜细胞、平滑肌细胞和卵细胞产生。 HA 注射用于减少脸部皱纹并增强软组织。

本报告提供玻尿酸填充物市场相关调查，提供产品概要与正在开发的开发中产品趋势，参与企业的最近的趋势等资讯。

目录

第1章 目录

第2章 简介

• 玻尿酸填充物概要

第3章 开发中的产品

• 玻尿酸填充物- 各开发阶段的开发中产品
• 玻尿酸填充物- 各市场区隔的开发中产品
• 玻尿酸填充物- 各地区的开发中产品
• 玻尿酸填充物- 各法规途径的开发中产品
• 玻尿酸填充物- 估计核准日的开发中产品
• 玻尿酸填充物- 进行中的临床试验

第4章 玻尿酸填充物- 各公司正在开发的开发中产品

• 玻尿酸填充物企业- 各开发阶段的开发中产品
• 玻尿酸填充物- 各开发阶段的开发中产品

第5章 玻尿酸填充物的企业和产品概要

• Allergan Aesthetics
• Almirall Ltd
• Aquavit Pharmaceuticals Inc
• BioPlus Co Ltd
• BioSmart Nanotechnology Ltda
• BMG Pharma SpA
• Bmi Korea Co Ltd
• CellPraxis
• Collplant Biotechnologies Ltd
• Croma-Pharma GmbH
• Evolus Inc
• Fillmed Laboratoires
• Hallura Ltd
• Hugel Inc
• Jinwoo Bio Co Ltd
• Laboratoires Vivacy
• LG Chem Ltd
• LifeSprout Inc
• Medytox Inc
• Merz Aesthetics
• Mesoestetic Pharma Group SL
• Oligo Medic Inc
• Q-Med AB
• Shanghai Haohai Biological Technology Co Ltd
• Shin Poong Pharm Co Ltd
• Silk Medical Aesthetics Inc
• Sinclair Pharma Ltd
• SwiftPharma BV
• Teoxane SA
• Tissueform Inc
• TruElastin Laboratories Inc

第6章 玻尿酸填充物- 最近的趋势

第7章 附录

• 调查手法
• 关于GlobalData
• 询问
• 免责声明

GlobalData's Medical Devices sector report, "Hyaluronic Acid Fillers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Hyaluronic Acid Fillers pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Hyaluronic Acid (HA) is a glycosaminoglycan disaccharide, which exists naturally in the body. Approximately 50% of total HA is found in the skin, and it is produced by dermal fibroblasts, endothelial cells, synovial cells, adventitial cells, smooth muscle cells, and oocytes. Injections of HA are used for reducing wrinkles in the face and for soft tissue augmentation.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

• Extensive coverage of the Hyaluronic Acid Fillers under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Hyaluronic Acid Fillers and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
• Identify and understand important and diverse types of Hyaluronic Acid Fillers under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2 Introduction

• 2.1 Hyaluronic Acid Fillers Overview

3 Products under Development

• 3.1 Hyaluronic Acid Fillers - Pipeline Products by Stage of Development
• 3.2 Hyaluronic Acid Fillers - Pipeline Products by Segment
• 3.3 Hyaluronic Acid Fillers - Pipeline Products by Territory
• 3.4 Hyaluronic Acid Fillers - Pipeline Products by Regulatory Path
• 3.5 Hyaluronic Acid Fillers - Pipeline Products by Estimated Approval Date
• 3.6 Hyaluronic Acid Fillers - Ongoing Clinical Trials

4 Hyaluronic Acid Fillers - Pipeline Products under Development by Companies

• 4.1 Hyaluronic Acid Fillers Companies - Pipeline Products by Stage of Development
• 4.2 Hyaluronic Acid Fillers - Pipeline Products by Stage of Development

5 Hyaluronic Acid Fillers Companies and Product Overview

• 5.1 Allergan Aesthetics Company Overview
  • 5.1.1 Allergan Aesthetics Pipeline Products & Ongoing Clinical Trials Overview
• 5.2 Almirall Ltd Company Overview
  • 5.2.1 Almirall Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.3 Aquavit Pharmaceuticals Inc Company Overview
  • 5.3.1 Aquavit Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.4 BioPlus Co Ltd Company Overview
  • 5.4.1 BioPlus Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.5 BioSmart Nanotechnology Ltda Company Overview
  • 5.5.1 BioSmart Nanotechnology Ltda Pipeline Products & Ongoing Clinical Trials Overview
• 5.6 BMG Pharma SpA Company Overview
  • 5.6.1 BMG Pharma SpA Pipeline Products & Ongoing Clinical Trials Overview
• 5.7 Bmi Korea Co Ltd Company Overview
  • 5.7.1 Bmi Korea Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.8 CellPraxis Company Overview
  • 5.8.1 CellPraxis Pipeline Products & Ongoing Clinical Trials Overview
• 5.9 Collplant Biotechnologies Ltd Company Overview
  • 5.9.1 Collplant Biotechnologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.10 Croma-Pharma GmbH Company Overview
  • 5.10.1 Croma-Pharma GmbH Pipeline Products & Ongoing Clinical Trials Overview
• 5.11 Evolus Inc Company Overview
  • 5.11.1 Evolus Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.12 Fillmed Laboratoires Company Overview
  • 5.12.1 Fillmed Laboratoires Pipeline Products & Ongoing Clinical Trials Overview
• 5.13 Hallura Ltd Company Overview
  • 5.13.1 Hallura Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.14 Hugel Inc Company Overview
  • 5.14.1 Hugel Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.15 Jinwoo Bio Co Ltd Company Overview
  • 5.15.1 Jinwoo Bio Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.16 Laboratoires Vivacy Company Overview
  • 5.16.1 Laboratoires Vivacy Pipeline Products & Ongoing Clinical Trials Overview
• 5.17 LG Chem Ltd Company Overview
  • 5.17.1 LG Chem Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.18 LifeSprout Inc Company Overview
  • 5.18.1 LifeSprout Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.19 Medytox Inc Company Overview
  • 5.19.1 Medytox Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.20 Merz Aesthetics Company Overview
  • 5.20.1 Merz Aesthetics Pipeline Products & Ongoing Clinical Trials Overview
• 5.21 Mesoestetic Pharma Group SL Company Overview
  • 5.21.1 Mesoestetic Pharma Group SL Pipeline Products & Ongoing Clinical Trials Overview
• 5.22 Oligo Medic Inc Company Overview
  • 5.22.1 Oligo Medic Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.23 Q-Med AB Company Overview
  • 5.23.1 Q-Med AB Pipeline Products & Ongoing Clinical Trials Overview
• 5.24 Shanghai Haohai Biological Technology Co Ltd Company Overview
  • 5.24.1 Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.25 Shin Poong Pharm Co Ltd Company Overview
  • 5.25.1 Shin Poong Pharm Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.26 Silk Medical Aesthetics Inc Company Overview
  • 5.26.1 Silk Medical Aesthetics Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.27 Sinclair Pharma Ltd Company Overview
  • 5.27.1 Sinclair Pharma Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.28 SwiftPharma BV Company Overview
  • 5.28.1 SwiftPharma BV Pipeline Products & Ongoing Clinical Trials Overview
• 5.29 Teoxane SA Company Overview
  • 5.29.1 Teoxane SA Pipeline Products & Ongoing Clinical Trials Overview
• 5.30 Tissueform Inc Company Overview
  • 5.30.1 Tissueform Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.31 TruElastin Laboratories Inc Company Overview
  • 5.31.1 TruElastin Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview

6 Hyaluronic Acid Fillers- Recent Developments

7 Appendix

• 7.1 Methodology
• 7.2 About GlobalData
• 7.3 Contact Us
• 7.4 Disclaimer

List of Tables

• Hyaluronic Acid Fillers - Pipeline Products by Stage of Development
• Hyaluronic Acid Fillers - Pipeline Products by Segment
• Hyaluronic Acid Fillers - Pipeline Products by Territory
• Hyaluronic Acid Fillers - Pipeline Products by Regulatory Path
• Hyaluronic Acid Fillers - Pipeline Products by Estimated Approval Date
• Hyaluronic Acid Fillers - Ongoing Clinical Trials
• Hyaluronic Acid Fillers Companies - Pipeline Products by Stage of Development
• Hyaluronic Acid Fillers - Pipeline Products by Stage of Development
• Glossary

List of Figures

• Hyaluronic Acid Fillers - Pipeline Products by Stage of Development
• Hyaluronic Acid Fillers - Pipeline Products by Segment
• Hyaluronic Acid Fillers - Pipeline Products by Territory
• Hyaluronic Acid Fillers - Pipeline Products by Regulatory Path
• Hyaluronic Acid Fillers - Pipeline Products by Estimated Approval Date
• Hyaluronic Acid Fillers - Ongoing Clinical Trials